Literature DB >> 23692738

Steroid-linked nitrogen mustards as potential anticancer therapeutics: a review.

Pijus Saha1, Chhanda Debnath, Gervais Bérubé.   

Abstract

Nitrogen mustards, an important class of drugs for cancer therapy, are known as DNA alkylating agents. The nitrogen mustards are highly reactive and, as a consequence, lack of selectivity and produce several adverse side effects. In order to minimize these undesirable effects, the attachment of nitrogen mustards to a steroidal hormone with affinity for its receptor can lead to highly selective and less toxic antineoplastic therapeutics. This review will focus on the design, synthesis and evaluation of such steroid-nitrogen mustard hybrids as antineoplastic agents. Among these compounds, modified steroids with aromatic nitrogen mustards linked by an ester function were found to have better DNA alkylating properties, improved selectivity as well as low toxicity. This article is part of a Special Issue entitled "Synthesis and biological testing of steroid derivatives as inhibitors".
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  4-Me-CABA; ACA; ADR; Anticancer agents; BCNU; CHL; CNC; CP; DTIC; DnsEM; EM; EMP; ER; EoM; HASE; ILS; LDL; MN; MNU; MeCCNU; Nitrogen mustard; PC; PHE; PHO; PRIs; RBA; SCEs; SMART; Steroid; Steroid-nitrogen mustard hybrids; adriamycin; aminocinnamic acid; carmustine; chlorambucil or para-[N,N-bis(2-chloroethyl)amino]phenylbutyric acid; chloronitrocarbamoyl; cisplatin; dacarbazine; dansyl estramustine; estramustine; estramustinephosphate; estrogen receptor; estromustine; homo-aza-steroidal alkylating ester; increase in lifespan; low-density lipoproteine; methylnitrosourea; micronuclei; para-[N,N-bis(2-chloroethyl)amino]phenoxy acetic acid; para-[N,N-bis(2-chloroethyl)amino]phenylacetic acid; para-methyl-meta-[N,N-bis(2-chloroethyl)amino]benzoic acid; proliferation rate indices; prostate cancer; rLDL; reconstituted-LDL; relative binding affinity; semustine; sister chromatid exchanges; somatic mutation and recombination test

Mesh:

Substances:

Year:  2013        PMID: 23692738     DOI: 10.1016/j.jsbmb.2013.05.004

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  5 in total

1.  Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates.

Authors:  Shengtao Xu; Lingling Pei; Chengqian Wang; Yun-Kai Zhang; Dahong Li; Hequan Yao; Xiaoming Wu; Zhe-Sheng Chen; Yijun Sun; Jinyi Xu
Journal:  ACS Med Chem Lett       Date:  2014-05-28       Impact factor: 4.345

2.  Identification of candidate drugs for the treatment of metastatic osteosarcoma through a subpathway analysis method.

Authors:  Xin Li; Ming-Lan Yan; Qian Yu
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

3.  A linear programming computational framework integrates phosphor-proteomics and prior knowledge to predict drug efficacy.

Authors:  Zhiwei Ji; Bing Wang; Ke Yan; Ligang Dong; Guanmin Meng; Lei Shi
Journal:  BMC Syst Biol       Date:  2017-12-21

Review 4.  Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing.

Authors:  Zhiqiang Ma; Liqun Xu; Dong Liu; Xiaoyan Zhang; Shouyin Di; Weimiao Li; Jiao Zhang; Russel J Reiter; Jing Han; Xiaofei Li; Xiaolong Yan
Journal:  Oxid Med Cell Longev       Date:  2020-05-21       Impact factor: 6.543

5.  Synthesis and conversion of primary and secondary 2-aminoestradiols into A-ring-integrated benzoxazolone hybrids and their in vitro anticancer activity.

Authors:  Ferenc Kovács; Mohana K Gopisetty; Dóra I Adamecz; Mónika Kiricsi; Éva A Enyedy; Éva Frank
Journal:  RSC Adv       Date:  2021-04-14       Impact factor: 3.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.